173 related articles for article (PubMed ID: 14657442)
21. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
22. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Angulo JC; Sanchez-Chapado M; Lopez JI; Flores N
J Urol; 1996 Jun; 155(6):1897-902. PubMed ID: 8618282
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
24. [Why use chemotherapy in cancer of the bladder? What are the initial limitations].
Maraninchi D; Viens P
Ann Urol (Paris); 1994; 28(6-7):334-7. PubMed ID: 7534457
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant chemotherapy for invasive bladder cancer].
Kageyama Y; Kihara K
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
[TBL] [Abstract][Full Text] [Related]
26. [A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies].
Matsumoto S; Nishioka T; Akiyama T; Park YC; Kurita T; Ishikawa Y
Hinyokika Kiyo; 2001 Jan; 47(1):43-6. PubMed ID: 11235221
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
[No Abstract] [Full Text] [Related]
28. [Preliminary clinical evaluation of systemic chemotherapy of invasive cancer of the bladder by the CMV protocol].
Szymanowski J; Koźmińska E; Malewski A; Stokłosa A
Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):525-7. PubMed ID: 1282711
[TBL] [Abstract][Full Text] [Related]
29. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
30. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
32. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
33. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
Sternberg CN
Prog Clin Biol Res; 1990; 353():143-52. PubMed ID: 2217412
[No Abstract] [Full Text] [Related]
34. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
[TBL] [Abstract][Full Text] [Related]
35. [Preoperative chemotherapy of locally disseminated cancer of the urinary bladder using methotrexate, vinblastine, platidiam and farmorubicin].
Matveev BP; Gadzhiev NG; Chevelidze ShG
Urol Nefrol (Mosk); 1988; (2):38-41. PubMed ID: 3164537
[No Abstract] [Full Text] [Related]
36. [Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
Maruyama T; Kondoh N; Nojima M; Yamamoto S; Mori Y; Shima H; Kamikonnya N; Hirota S; Nakao N
Hinyokika Kiyo; 2006 Jun; 52(6):445-9. PubMed ID: 16848358
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.
Splinter TA; Denis L; Scher HI; Schröder FH; Dalesio O
Prog Clin Biol Res; 1989; 303():541-7. PubMed ID: 2675011
[No Abstract] [Full Text] [Related]
38. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Keating JP; Zincke H; Hahn RG; Morgan WR
Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
[No Abstract] [Full Text] [Related]
39. Prognostic factors in bladder cancer after primary M-VAC.
Paz-Ares L; Paul J; Kaye S
J Clin Oncol; 1995 Jan; 13(1):300-2. PubMed ID: 7799035
[No Abstract] [Full Text] [Related]
40. Malignant urothelial carcinoma of urinary bladder in a young child: a rare case report.
Neogi S; Kariholu PL; Dhakre G; Gupta V; Agarwal N; Bhadani P
Urology; 2013 Apr; 81(4):888-90. PubMed ID: 23394879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
